Suivre
Marit Eika Jørgensen
Marit Eika Jørgensen
Clinical Epidemiology, Steno Diabetes Center
Adresse e-mail validée de steno.dk
Titre
Citée par
Citée par
Année
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
265202017
Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps
A Mahajan, D Taliun, M Thurner, NR Robertson, JM Torres, NW Rayner, ...
Nature genetics 50 (11), 1505-1513, 2018
17252018
The genetic architecture of type 2 diabetes
C Fuchsberger, J Flannick, TM Teslovich, A Mahajan, V Agarwala, ...
Nature 536 (7614), 41-47, 2016
12912016
Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative …
M Kosiborod, MA Cavender, AZ Fu, JP Wilding, K Khunti, RW Holl, ...
Circulation 136 (3), 249-259, 2017
7812017
An expanded genome-wide association study of type 2 diabetes in Europeans
RA Scott, LJ Scott, R Mägi, L Marullo, KJ Gaulton, M Kaakinen, ...
Diabetes 66 (11), 2888-2902, 2017
7732017
Rare and low-frequency coding variants alter human adult height
E Marouli, M Graff, C Medina-Gomez, KS Lo, AR Wood, TR Kjaer, RS Fine, ...
Nature 542 (7640), 186-190, 2017
6802017
Greenlandic Inuit show genetic signatures of diet and climate adaptation
M Fumagalli, I Moltke, N Grarup, F Racimo, P Bjerregaard, ME Jørgensen, ...
Science 349 (6254), 1343-1347, 2015
6062015
Exome-wide association study of plasma lipids in> 300,000 individuals
DJ Liu, GM Peloso, H Yu, AS Butterworth, X Wang, A Mahajan, ...
Nature genetics 49 (12), 1758-1766, 2017
5712017
Loss-of-function mutations in SLC30A8 protect against type 2 diabetes
J Flannick, G Thorleifsson, NL Beer, SBR Jacobs, N Grarup, NP Burtt, ...
Nature genetics 46 (4), 357-363, 2014
5562014
Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 study
M Kosiborod, CSP Lam, S Kohsaka, DJ Kim, A Karasik, J Shaw, N Tangri, ...
Journal of the American College of Cardiology 71 (23), 2628-2639, 2018
5012018
The trans-ancestral genomic architecture of glycemic traits
J Chen, CN Spracklen, G Marenne, A Varshney, LJ Corbin, J Luan, ...
Nature genetics 53 (6), 840-860, 2021
4872021
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes
A Mahajan, J Wessel, SM Willems, W Zhao, NR Robertson, AY Chu, ...
Nature genetics 50 (4), 559-571, 2018
4432018
A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes
I Moltke, N Grarup, ME Jørgensen, P Bjerregaard, JT Treebak, ...
Nature 512 (7513), 190-193, 2014
4312014
Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci
KJ Gaulton, T Ferreira, Y Lee, A Raimondo, R Mägi, ME Reschen, ...
Nature genetics 47 (12), 1415-1425, 2015
4292015
Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation
A Mahajan, CN Spracklen, W Zhang, MCY Ng, LE Petty, H Kitajima, ...
Nature genetics 54 (5), 560-572, 2022
4222022
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs …
KI Birkeland, ME Jørgensen, B Carstensen, F Persson, HL Gulseth, ...
The lancet Diabetes & endocrinology 5 (9), 709-717, 2017
3902017
Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes
V Steinthorsdottir, G Thorleifsson, P Sulem, H Helgason, N Grarup, ...
Nature genetics 46 (3), 294-298, 2014
3612014
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
V Turcot, Y Lu, HM Highland, C Schurmann, AE Justice, RS Fine, ...
Nature genetics 50 (1), 26-41, 2018
3592018
Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls
J Flannick, JM Mercader, C Fuchsberger, MS Udler, A Mahajan, J Wessel, ...
Nature 570 (7759), 71-76, 2019
3102019
GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study
K Færch, SS Torekov, D Vistisen, NB Johansen, DR Witte, A Jonsson, ...
Diabetes 64 (7), 2513-2525, 2015
3082015
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20